We analyzed serum MIC-1 in patients with lung cancer, and demonstrated the diagnostic significance of MIC-1 and the combination of MIC-1 with clinically available biomarkers to discriminate normal tissue from lung cancer, especially early-stage I/II lung cancer with high sensitivity without compromising specificity. The gene discussed is GDF15; the disease is lung cancer.